SARS-CoV-2 reinfection and severity of the disease: a systematic review and meta-analysis

NN Nguyen, YN Nguyen, VT Hoang, M Million… - Viruses, 2023 - mdpi.com
Since the discovery of SARS-CoV-2, changes in genotype and reinfection with different
variants have been observed in COVID-19-recovered patients, raising questions around the …

Quantifying the risk of SARS‐CoV‐2 reinfection over time

EO Murchu, P Byrne, PG Carty… - Reviews in medical …, 2022 - Wiley Online Library
Despite over 140 million SARS‐CoV‐2 infections worldwide since the beginning of the
pandemic, relatively few confirmed cases of SARS‐CoV‐2 reinfection have been reported …

The incidence of SARS-CoV-2 reinfection in persons with naturally acquired immunity with and without subsequent receipt of a single dose of BNT162b2 vaccine: a …

S Gazit, R Shlezinger, G Perez, R Lotan… - Annals of Internal …, 2022 - acpjournals.org
Background: There is insufficient evidence regarding the magnitude and durability of
protection conferred by a combined effect of naturally acquired immunity after SARS-CoV-2 …

Differences in the concentration of anti-SARS-CoV-2 IgG antibodies post-COVID-19 recovery or post-vaccination

A Tretyn, J Szczepanek, M Skorupa… - Cells, 2021 - mdpi.com
At the end of 2020, population-based vaccination programs with new generation mRNA-
based vaccines began almost all over the world. The aim of the study was to evaluate the …

[HTML][HTML] Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity: reinfections versus breakthrough infections

S Gazit, R Shlezinger, G Perez, R Lotan, A Peretz… - MedRxiv, 2021 - medrxiv.org
Background Reports of waning vaccine-induced immunity against COVID-19 have begun to
surface. With that, the comparable long-term protection conferred by previous infection with …

The prevalence of adaptive immunity to COVID-19 and reinfection after recovery–a comprehensive systematic review and meta-analysis

T Chivese, JT Matizanadzo, OAH Musa… - Pathogens and global …, 2022 - Taylor & Francis
This study aims to estimate the prevalence and longevity of detectable SARS-CoV-2
antibodies and T and B memory cells after recovery. In addition, the prevalence of COVID-19 …

Modelling COVID-19 vaccine breakthrough infections in highly vaccinated Israel—the effects of waning immunity and third vaccination dose

A Feng, U Obolski, L Stone, D He - PLOS global public health, 2022 - journals.plos.org
In August 2021, a major wave of the SARS-CoV-2 Delta variant erupted in the highly
vaccinated population of Israel. The transmission advantage of the Delta variant enabled it …

Reinfection or reactivation of severe acute respiratory syndrome coronavirus 2: a systematic review

X Tang, SS Musa, S Zhao, D He - Frontiers in public health, 2021 - frontiersin.org
As the pandemic continues, individuals with re-detectable positive (RP) SARS-CoV-2 viral
RNA among recovered COVID-19 patients have raised public health concerns. It is …

Severe acute respiratory syndrome coronavirus 2 reinfection associates with unstable housing and occurs in the presence of antibodies

DJ Bean, J Monroe, J Turcinovic… - Clinical Infectious …, 2022 - academic.oup.com
Background The factors associated with severe acute respiratory coronavirus 2 (SARS-CoV-
2) reinfection remain poorly defined. Methods We identified patients with SARS-CoV-2 …

The unexpected dynamics of COVID-19 in Manaus, Brazil: Was herd immunity achieved?

D He, Y Artzy-Randrup, SS Musa, T Gräf, F Naveca… - MedRxiv, 2021 - medrxiv.org
Abstract In late March 2020, SARS-CoV-2 arrived in Manaus, Brazil, and rapidly developed
into a large-scale epidemic that collapsed the local health system, and resulted in extreme …